Half-year report · Q2
4937.TEDINET S100VR3K
Period2024-10-01 → 2025-03-31
Filed2025-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥835m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥1.9bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥934m | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | −¥52m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | −¥87m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥57m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥84m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥84m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥17m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥111m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | −¥111m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥3.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥964m | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥993m | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.1bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥49m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥67m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥88m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥76m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥12m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥123m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥112m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥130m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-16.36 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.03 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-33.54 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 67.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥187m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥503m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥503m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥144m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥332m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥332m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥9m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥135m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥75,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥75,000 |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥200m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥712m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥712m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥75,000 |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥154m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥222m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥222m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥42m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥934m |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥934m |
| —segment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥75,000 |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥113m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 432
| Item | Context | Value | Unit |
|---|---|---|---|
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2024-10-01 | |
| Current period end date | FilingDateInstant | 2025-03-31 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2025-09-30 | |
| Previous fiscal year start date | FilingDateInstant | 2023-10-01 | |
| Comparative period end date | FilingDateInstant | 2024-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2024-09-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所(グロース) | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式であります。単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)相川 佳之 | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)（神奈川県横浜市戸塚区） | |
| Name major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)井上 裕基 | |
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)ＳＢＣメディカルグループ株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)神奈川県横浜市戸塚区上倉田町908番地 | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社Ｍ＆Ｍ | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)東京都港区港区浜松町２丁目２－15 浜松町ダイヤビル２F | |
| Name major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)Ｅｎｖｉｒｏｎｍｅｎｔ Ｆｉｒｓｔ投資事業組合 | |
| Address major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)東京都港区新橋２丁目19－４ＳＮＴビル11Ｆ | |
| Name major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)福留 大士 | |
| Address major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)東京都中央区 | |
| Name major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)株式会社日本カストディ銀行（信託口） | |
| Address major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)東京都中央区晴海１丁目８－12 | |
| Name major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)前田 敏彦 | |
| Address major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)東京都渋谷区 | |
| Name major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)株式会社ＳＢＩ証券 | |
| Address major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)東京都港区六本木１丁目６番１号 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |